Scientific Advisors

Jeanne L. Becker, Ph.D. is a scientific advisor to Nano3D Biosciences. Dr. Becker was the founding President, CEO and Executive Director of the Center for the Advancement of Science in Space (CASIS), the management organization for the International Space Station (ISS) U.S. National Laboratory. Her previous posts include serving as Associate Director of the John M. Eisenberg Center for Clinical Decisions and Communications Science, a partner organization to the United States Agency for Healthcare Research and Quality; Vice President and Associate Director of the National Space Biomedical Research Institute, a partner organization to NASA; and Chair of the National Advisory Committee for the Women’s Health Research Coalition, a Washington D.C.-based network of leaders in academic medical, health and scientific institutions. Dr. Becker also served as Chief Science Officer for Astrogenetix, Inc., and was part of the research team using the conditions of microgravity to uncover novel targets for the development of bacterial vaccines and therapeutics. These pathfinder missions were designed by NASA as a national priority to validate the use of space for new biomedical discovery, and to demonstrate the value and importance of ISS as a research platform. The work resulted in the development of a novel in-flight method to assess host-pathogen interactions and microbial virulence in microgravity. Dr. Becker has held faculty positions at Baylor College of Medicine and the University of South Florida College of Medicine, where her research focused on the development of three dimensional models of human breast and ovarian cancer, using the Rotating Wall Vessel developed by NASA. The three dimensional cellular constructs generated in these models reproduce many aspects of cancer, by creating tissue like architecture that exhibits rapid onset drug resistance as occurs in human disease. This work was selected as part of the suite of the first cell culture studies performed aboard the ISS, on Increment 3. In addition, she has developed a three dimensional cell culture paradigm based upon diamagnetically stabilized magnetic levitation, with two patents filed on this technology. Dr. Becker has had the opportunity to testify on several occasions before the United States Congress on her work and on the space program’s contributions to medical research, and is a recipient of NASA Space Life Sciences Directorate Professional Achievement Award.

J. Houston Miller, Ph.D. is a professor of Chemistry at The George Washington University (GWU). His distinguished scientific career includes over 100 scientific publications and several government-funded grant proposals. Prof. Miller’s multidisciplinary research is generally focused on the development and interpretation of diagnostics based on solid-state laser technologies for a broad range of applications in biology, the development of nanoparticles-based bio-inorganic materials, atmospheric and industrial sensing, and combustion chemistry. In addition to his impressive publication record and broad scientific background, Prof. Miller is an inventor with five patents or patent applications. Importantly, the technology based on some of these patents has been licensed from GWU and is the basis of a new line of ultrasensitive optical sensors that will be applied to problems in a wide range of atmospheric and industrial markets. In addition to his appointment at GWU, Miller is a Visiting Professor in the Chemical Engineering Department of Cambridge University and is a Bye Fellow of Robinson College, also in Cambridge, England.

Karel Petrak, Ph.D. is president & CEO of PJP Innovations Inc., a consulting company specializing in the pharmaceutical and biotechnology areas and covering all aspects of drug development. Dr. Petrak obtained his Ph.D. from Sussex University studying organic and macromolecular chemistry and applications to breast cancer. His experience working in industry has focused on targeted drug delivery systems using nanoparticles or carbohydrate-based targeting, working with partners in the Texas Medical Center on pre-clinical and clinical aspects of drug development. Dr. Petrak has raised over $10 million in NIH funding to support these various projects.

Jordan Miller, Ph.D. is an Assistant Professor of Bioengineering at Rice University and the Director of the Laboratory for Microphysiologic Systems Engineering and Advanced Materials at Rice University. His research group seeks to uncover the rules which govern how cells form tissues and, in turn, organs using an engineering approach. Dr. Miller brings to n3D over 10 years of experience in biomaterials, tissue engineering, molecular imaging, microfabrication, and 3D printing.